PriceTargets.com logo

Ayr Wellness - AYRWF Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $3.00
  • Forecasted Upside: 581.82%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 1 Strong Buy Ratings
$0.44 As of 12/20/2024 06:55 PM ET
▲ +0.0099 (2.30%)

This chart shows the closing price for AYRWF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ayr Wellness Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AYRWF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AYRWF

Analyst Price Target is $3.00
▲ +581.82% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Ayr Wellness in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 581.82% upside from the last price of $0.44.

This chart shows the closing price for AYRWF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 investment analysts is to moderate buy stock in Ayr Wellness. This rating has held steady since June 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/21/2024
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/14/2024Roth MkmLower TargetBuy ➝ Buy$3.50 ➝ $3.00
11/13/2024Atb Cap MarketsDowngradeHold ➝ Strong Sell
11/8/2024Roth CapitalUpgradeStrong-Buy
7/5/2023ATB CapitalInitiated CoverageBuy
5/19/2023Needham & Company LLCDowngradeBuy ➝ Hold
3/9/2023Needham & Company LLCReiterated RatingBuy$4.75 ➝ $3.75
11/11/2022Cantor FitzgeraldLower TargetNeutral$4.65 ➝ $4.25
10/28/2022BTIG ResearchInitiated CoverageBuy
9/30/2022Atb Cap MarketsReiterated RatingOutperform
8/19/2022Cantor FitzgeraldLower TargetNeutral$6.75 ➝ $4.65
8/19/2022Canaccord Genuity GroupLower TargetBuy ➝ BuyC$40.00 ➝ C$30.00
8/19/2022Northland SecuritiesLower Target$14.00 ➝ $10.00
7/22/2022Seaport Res PtnReiterated RatingBuy
5/27/2022Echelon Wealth PartnersReiterated RatingBuy$45.00
3/18/2022Canaccord Genuity GroupLower TargetBuy ➝ BuyC$57.00 ➝ C$40.00
3/18/2022Needham & Company LLCLower TargetBuy$28.00 ➝ $21.00
3/18/2022Cantor FitzgeraldLower TargetNeutral$17.50 ➝ $13.30
3/3/2022Needham & Company LLCLower TargetBuy$35.00 ➝ $28.00
12/2/2021Cantor FitzgeraldLower TargetNeutral$22.60 ➝ $17.50
11/3/2021Cantor FitzgeraldLower TargetNeutral$33.50 ➝ $22.60
10/1/2021Echelon Wealth PartnersReiterated RatingBuy$75.00
8/30/2021Echelon Wealth PartnersReiterated RatingBuyC$75.00
7/7/2021Jefferies Financial GroupInitiated CoverageBuy$80.00
5/12/2021Echelon Wealth PartnersReiterated RatingBuy$70.00
3/16/2021Cantor FitzgeraldLower TargetNeutral$39.00 ➝ $36.00
2/11/2021Cantor FitzgeraldBoost TargetNeutral$31.00 ➝ $39.00
2/3/2021Cantor FitzgeraldBoost TargetNeutral$24.50 ➝ $31.00
1/6/2021Northland SecuritiesReiterated RatingTop Pick
12/28/2020Cantor FitzgeraldBoost Target$24.00 ➝ $24.50
12/27/2020Echelon Wealth PartnersReiterated RatingBuy$53.00
12/23/2020Needham & Company LLCReiterated RatingBuy$32.50
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.27 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 9 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Ayr Wellness logo
Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.
Read More

Today's Range

Now: $0.44
Low: $0.43
High: $0.48

50 Day Range

MA: $1.16
Low: $0.40
High: $2.44

52 Week Range

Now: $0.44
Low: $0.38
High: $4.09

Volume

309,659 shs

Average Volume

303,719 shs

Market Capitalization

$51.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Frequently Asked Questions

What sell-side analysts currently cover shares of Ayr Wellness?

The following Wall Street research analysts have issued research reports on Ayr Wellness in the last twelve months: Atb Cap Markets, Roth Capital, and Roth Mkm.
View the latest analyst ratings for AYRWF.

What is the current price target for Ayr Wellness?

0 Wall Street analysts have set twelve-month price targets for Ayr Wellness in the last year. Their average twelve-month price target is $3.00, suggesting a possible upside of 581.8%. Roth Mkm has the highest price target set, predicting AYRWF will reach $3.00 in the next twelve months. Roth Mkm has the lowest price target set, forecasting a price of $3.00 for Ayr Wellness in the next year.
View the latest price targets for AYRWF.

What is the current consensus analyst rating for Ayr Wellness?

Ayr Wellness currently has 1 sell rating, 1 buy rating and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AYRWF.

What other companies compete with Ayr Wellness?

Other companies that are similar to Ayr Wellness include Solid Biosciences, Kyverna Therapeutics, MediWound, Sagimet Biosciences and TuHURA Biosciences. Learn More about companies similar to Ayr Wellness.

How do I contact Ayr Wellness' investor relations team?

The company's listed phone number is 949-574-3860 and its investor relations email address is [email protected]. The official website for Ayr Wellness is www.ayrstrategies.com. Learn More about contacing Ayr Wellness investor relations.